Dasatinib 20mg Tablets Exporters

* To be consumed as directed by physician.

Dasatinib 20mg Tablets

Dasatinib (20mg)
  • Dasatinib 20mg tablet is a chemotherapy drug. It is an ATP-competitive protein tyrosine kinase inhibitor. It mainly targets BCR/ABI (the Philadelphia chromosome), SRC, c-Kit, ephrin receptors, and several other tyrosine kinases. Dasatinib Tablets has half-life plasma that is active only for 3 to 4 hours, but the strong binding to BCR-ABL1 helps it to stay active for a long time, and this is the uniqueness of Dasatinib when compared to other CML treatments.
  • The dosage of the medicine depends upon the severity of the complications of the disease and it may vary gradually depending on the response of the body to the medicine.
  • Dasatinib 20mg is used to treat cases of Chronic Myelogenous Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL), and Philadelphia Chromosome-positive (Ph+).
  • It blocks the action of abnormal protein that strengthens the cancer cells to multiply.
  • It stops or slows down the growth of cancer cells in the body.
  • It treats the adults in chronic phase of Philadelphia Chromosome-positive (Ph+) who have no benefits from or couldn’t tolerate other treatments and children who have chronic Ph+ CML.
  • If you experience hand-foot syndrome or PPE which means rashes, swelling, redness, pain/peeling off of the skin in the hand palms and feet soles immediately after two weeks of the treatment, see your doctor, he/she might alter the dose of the medicine.
  • Consult your medical help immediately if the "after effects" are severe and bother your health.
(4.5 Rating)

Product Enquiry

Send Message